Evidence map›Paper›PMID 37424566›Full record

ArticleAccess microbiology2023

An unusual presentation of

Catherine S Hwang, Elham Rahmati, Anthony J Gerbino, Tracie M Rose, Punam Verma, Margot A Schwartz

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Access microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. A case report ofFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Catherine S HwangSection of Graduate Medical Education, Virginia Mason Medical Center, Seattle, WA, USA.
Elham RahmatiSection of Infectious Diseases, Virginia Mason Medical Center, Seattle, WA, USA.
Anthony J GerbinoSections of Critical Care Medicine, Pulmonary Medicine, and Undersea and Hyperbaric Medicine, Virginia Mason Medical Center, Seattle, WA, USA.
Tracie M RoseSection of Clinical Microbiology, Department of Pathology and Laboratory Medicine, Virginia Mason Medical Center, Seattle, WA, USA.
Punam VermaSection of Clinical Microbiology, Department of Pathology and Laboratory Medicine, Virginia Mason Medical Center, Seattle, WA, USA.
Margot A SchwartzSection of Infectious Diseases, Virginia Mason Medical Center, Seattle, WA, USA.ORCID https://orcid.org/0000-0001-6885-1512
Virginia Mason Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Case Presentation: An 80-year-old man with myeloproliferative disorder on ruxolitinib presented with several days of worsening abdominal pain, which rapidly developed into septic shock with multi-organ failure and explosive diarrhea. Gram-negative bacilli observed on Gram staining of his blood culture broth were later identified as Conclusion:

Indexed as

bacteremiaCampylobacterhumaninfectionPseudomonas

Identifiers

PMID37424566
PMCPMC10323798
OpenAlexW4381251500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.